Stocks are higher despite orders for durable goods suffering their biggest drop in nearly a year in July.
The biotech's decision to buy privately held Proteolix in October 2009 was a jackpot.
Expect to see more mergers and acquisitions activity focused on cancer drugs.
Strong Asian and European manufacturing reports boost global stocks, and US markets seem set to follow.
Also in focus is the first reading of second quarter GDP as well as a slew of other economic data.
The sector is filled with speculation, risk, and potentially high reward. The fate of these 2 companies illustrates this.
The leader in the treatment of HIV/AIDS can also own the hepatitis C market.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
If your wallet is running on empty but you still have more shopping to do, we've got you covered. Here are 10 cool kid gifts that won't break the bank.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.